Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 484,000 | 326,000 | 167,000 | 668,000 | 512,000 |
| Depreciation Amortization | 146,000 | 93,000 | 46,000 | 178,000 | 134,000 |
| Income taxes - deferred | 180,000 | 127,000 | 59,000 | 194,000 | 159,000 |
| Accounts receivable | -141,000 | -50,000 | -9,000 | -97,000 | -74,000 |
| Accounts payable and accrued liabilities | 32,000 | 48,000 | 30,000 | 42,000 | 60,000 |
| Other Working Capital | -358,000 | -250,000 | -152,000 | -242,000 | -209,000 |
| Other Operating Activity | -57,000 | -82,000 | -33,000 | -198,000 | -174,000 |
| Operating Cash Flow | $286,000 | $212,000 | $108,000 | $545,000 | $408,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -226,000 | -146,000 | -65,000 | -184,000 | -122,000 |
| Net Acquisitions | -601,000 | -614,000 | N/A | N/A | N/A |
| Purchase Of Investment | -2,253,000 | -1,658,000 | -740,000 | -1,747,000 | -1,264,000 |
| Sale Of Investment | 2,563,000 | 1,948,000 | 567,000 | 1,557,000 | 1,142,000 |
| Purchase Sale Intangibles | -34,000 | -15,000 | -16,000 | -131,000 | -120,000 |
| Other Investing Activity | -6,000 | 1,000 | -11,000 | -109,000 | -104,000 |
| Investing Cash Flow | $-523,000 | $-469,000 | $-249,000 | $-483,000 | $-348,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 343,000 | 329,000 | 127,000 | 66,000 | 62,000 |
| Debt Issued | N/A | N/A | N/A | 46,000 | 46,000 |
| Debt Repayment | N/A | N/A | N/A | -46,000 | N/A |
| Common Stock Issued | 84,000 | 86,000 | 1,000 | 10,000 | 9,000 |
| Dividend Paid | -78,000 | -80,000 | N/A | -80,000 | -80,000 |
| Other Financing Activity | -42,000 | -28,000 | -13,000 | -41,000 | -76,000 |
| Financing Cash Flow | $307,000 | $307,000 | $115,000 | $-45,000 | $-39,000 |
| Exchange Rate Effect | N/A | N/A | 1,000 | -1,000 | N/A |
| Beginning Cash Position | 83,000 | 85,000 | 85,000 | 69,000 | 69,000 |
| End Cash Position | 152,000 | 135,000 | 59,000 | 85,000 | 91,000 |
| Net Cash Flow | $69,000 | $50,000 | $-26,000 | $16,000 | $22,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 286,000 | 212,000 | 108,000 | 545,000 | 408,000 |
| Capital Expenditure | -232,000 | -151,000 | -67,000 | -197,000 | -134,000 |
| Free Cash Flow | 54,000 | 61,000 | 41,000 | 348,000 | 274,000 |